Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease (BEST).

Trial Profile

Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease (BEST).

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BEST
  • Most Recent Events

    • 20 Sep 2016 Pooled analysis (n=1166) of individual patient-level data of the SYNTAX and BEST trials published in the Heart.
    • 16 Mar 2015 Status changed from active, no longer recruiting to discontinued according to results published in the New England Journal of Medicine.
    • 25 Jul 2014 Planned End Date changed from 1 Dec 2015 to 1 May 2019 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top